Summary : The Food and Drug Administration (FDA) has approved a novel first-in-class drug to…
FDA
-
-
U.S FDA
Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA™ TRIPLE PAK™ (Vonoprazan, Amoxicillin, Clarithromycin) and VOQUEZNA™ DUAL PAK™ (Vonoprazan, Amoxicillin) for the Treatment of H. pylori Infection in Adults
by adminSummary : The FDA approved two vonoprazan-based regimens, one with amoxicillin and clarithromycin (Voquezna Triple…
-
Summary : HYFTOR™ is the first topical treatment approved by the FDA for facial angiofibroma in…
-
Summary: EPSOLAY (benzoyl peroxide, cream, 5%) utilizes Sol-Gel’s proprietary microencapsulation technology for the treatment of…
-
U.S FDA
Alymsys® (Bevacizumab-maly), a Biosimilar of Bevacizumab developed by mAbxience, has been Approved by the FDA.
by adminSummary : ALYMSYS® was developed by mAbxience, a global biotech company with over a decade of…
-
Summary : Five Prime’s lead asset, Bemarituzumab, is a first-in-class, Phase 3 ready anti-FGFR2b antibody…
-
U.S FDA
First Generic of Symbicort (Budesonide and Formoterol Fumarate Dihydrate) Receives FDA Approval
by adminSummary : The U.S. Food and Drug Administration approved the first generic of Symbicort (budesonide…
-
Summary : Today, the U.S. Food and Drug Administration approved the first generic of Symbicort…
-
Summary : Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced an initial donation of essential…
-
U.S FDA
Expert: Newly Appointed FDA Commissioner Robert Califf Is Perfectly Positioned to Advance the FDA’s Accelerated Approval Pathway
by adminSummary : Peter Pitts, a former FDA associate commissioner and president of the Center for…